 |
N-(5-(6-chloro-2,2-difluorobenzo[d][1,3]dioxol-5-yl)pyrazin-2-yl)-2-fluoro-6-methylbenzamide |
|---|---|
| Trade Name | |
| Orphan Indication | Acute pancreatitis |
| EU Market Approval | EU |
| EU Designation Date | 2016-11-18 00:00:00 |
| Sponsor | Cogas Pharma Limited |
| |
N-(5-(6-chloro-2,2-difluorobenzo[d][1,3]dioxol-5-yl)pyrazin-2-yl)-2-fluoro-6-methylbenzamide |
|---|---|
| Trade Name | |
| Orphan Indication | Acute pancreatitis |
| EU Market Approval | EU |
| EU Designation Date | 2016-11-18 00:00:00 |
| Sponsor | Cogas Pharma Limited |